Life Science Alliance
Drug helps human immune cells fight bacteria in the lab
In laboratory experiments, K21 improved bacterial uptake by human immune cells while reducing the bacteria’s ability to cause infection within them.In laboratory experiments, K21 improved bacterial uptake by human immune cells while reducing the bacteria’s ability to cause infection within them.
Human cell studyBlood and immune system
Who was studiedHuman monocyte-derived macrophages, against untreated M2 controls
What changedFew bacterial colonies formed from M2 macrophages pretreated with K21 compared with untreated M2 controls
The catchK21 was provided by FiteBac LLC
